1. Home
  2. FSBC vs PHAR Comparison

FSBC vs PHAR Comparison

Compare FSBC & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Five Star Bancorp

FSBC

Five Star Bancorp

HOLD

Current Price

$44.47

Market Cap

860.4M

Sector

Finance

ML Signal

HOLD

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

HOLD

Current Price

$12.42

Market Cap

885.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FSBC
PHAR
Founded
2002
1988
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
860.4M
885.7M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
FSBC
PHAR
Price
$44.47
$12.42
Analyst Decision
Buy
Strong Buy
Analyst Count
5
3
Target Price
$41.90
$38.33
AVG Volume (30 Days)
87.4K
9.6K
Earning Date
04-27-2026
05-07-2026
Dividend Yield
2.47%
N/A
EPS Growth
28.32
N/A
EPS
0.87
N/A
Revenue
N/A
N/A
Revenue This Year
$30.25
$10.04
Revenue Next Year
$12.30
$2.51
P/E Ratio
$50.64
$3,041.22
Revenue Growth
N/A
N/A
52 Week Low
$26.26
$9.54
52 Week High
$44.99
$21.34

Technical Indicators

Market Signals
Indicator
FSBC
PHAR
Relative Strength Index (RSI) 69.91 39.90
Support Level $39.93 $11.84
Resistance Level N/A $13.61
Average True Range (ATR) 1.06 0.47
MACD 0.17 0.08
Stochastic Oscillator 87.40 29.83

Price Performance

Historical Comparison
FSBC
PHAR

About FSBC Five Star Bancorp

Five Star Bancorp is a bank holding company that operates in California through its subsidiary, a state-chartered non-member bank. The company provides a broad range of banking products and services to small and medium-sized businesses, professionals, and individuals. It offers loan products like commercial real estate loans, commercial loans, commercial land and construction loans, and farmland loans, and offers deposit products like checking accounts, savings accounts, money market accounts, and term certificate accounts. The group has one reportable operating segment: Banking.

About PHAR Pharming Group N.V.

Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.

Share on Social Networks: